Breast Cancer Female Clinical Trials

24 studies are recruiting for breast cancer female in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Boston, Massachusetts 6 Pittsburgh, Pennsylvania 3

Studies now recruiting

  1. ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

    AUDIBLE is a multi-site, clinical study conducted in the United States aimed at gathering data on 3D Automated Breast Ultrasound imaging using the iSono Health ATUSA system. The study focuses on female participants who have previously been identified with suspicious findings (classified as BIRADs 4…

    Stage
    Not phased
    Ages
    18 to 94
    Site
    UC Davis, Sacramento, California
    Locations
    2 in total
    Run by
    iSono Health, Inc.

    See if you can join NCT07505797 on ClinicalTrials.gov

  2. Biennial CEM in Women With a Personal History of Breast Cancer

    This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.

    Stage
    Not phased
    Ages
    30 to 79
    Site
    UPMC Magee-Womens Imaging - Bethel Park, Bethel Park, Pennsylvania
    Locations
    6 in total
    Run by
    Wendie Berg

    See if you can join NCT06105749 on ClinicalTrials.gov

  3. Supporting Health Including Endocrine Treatment for Long Duration

    This research is being done to pilot an intervention which aims to test a new web- and mobile application ("app")-based supportive care tool (SHIELD portal) and to assess the feasibility of enrolling female breast cancer patients with hormone receptor-positive disease long-term endocrine treatment.

    Stage
    Not phased
    Ages
    18 to 49
    Site
    Dana-Farber Cancer Institute, Boston, Massachusetts
    Run by
    Dana-Farber Cancer Institute

    See if you can join NCT07482384 on ClinicalTrials.gov

  4. DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

    The purpose of this study is to test the safety and effectiveness of the study drug datopotamab deruxtecan in participants with metastatic breast cancer that has spread to the brain. The name of the study drug used in this research study is: Datopotamab deruxtecan (a type of antibody-drug conjugate)

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Miami Baptist Cancer Institute/, Miami, Florida
    Locations
    3 in total
    Run by
    Nancy Lin, MD

    See if you can join NCT06176261 on ClinicalTrials.gov

  5. The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer

    The purpose of this study is to test the safety and effectiveness of a sequence of drugs (a Taxane plus Trastuzumab plus Pertuzumab followed by Trastuzumab Deruxtecan, followed by Tucatinib plus Ado-Trastuzumab Emtansine (T-DM1), followed by Trastuzumab plus Pertuzumab plus Tucatinib) in HER2+ Brea…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Dana-Farber Cancer Institute, Boston, Massachusetts
    Run by
    Dana-Farber Cancer Institute

    See if you can join NCT06439693 on ClinicalTrials.gov

  6. TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

    This research is being done to assess whether an exercise intervention with protein intake support vs a health education and support program will make it easier for women age 65 or older who are receiving chemotherapy for breast cancer to receive all of their planned chemotherapy according to sched…

    Stage
    Not phased
    Ages
    65 and older
    Site
    Dana Farber Cancer Institute, Boston, Massachusetts
    Locations
    4 in total
    Run by
    Dana-Farber Cancer Institute

    See if you can join NCT05535192 on ClinicalTrials.gov

  7. Pre-Operative Window of ET to Inform RT Decisions (POWER II)

    This is a Phase III, multisite exploratory study for women ≥ 65 years of age with early stage estrogen receptor positive (ER+) breast cancer. These individuals will be treated randomly assigned to one of two groups: Intervention, treated with 3 months of pre-operative endocrine therapy (pre-ET) OR …

    Stage
    Phase 3
    Ages
    65 and older
    Site
    Yale University, New Haven, Connecticut
    Locations
    6 in total
    Run by
    University of Virginia

    See if you can join NCT06507618 on ClinicalTrials.gov

  8. ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

    The goal of this study is to evaluate the safety and efficacy of elacestrant in combination with trastuzumab deruxtecan (T-DXd) in participants with hormone receptor-positive (HR+), HER2-low or HER2-ultralow, metastatic breast cancer that is resistant to prior CDK4/6 inhibitor and endocrine therapy…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Dana-Farber Cancer Institute, Boston, Massachusetts
    Run by
    Kristina A. Fanucci

    See if you can join NCT07198724 on ClinicalTrials.gov

  9. Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

    The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah
    Run by
    University of Utah

    See if you can join NCT07120100 on ClinicalTrials.gov

  10. Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

    Study is enrolling newly diagnosed breast cancer patients about to start chemotherapy and age-matched control participants. The investigator is trying to better understand the prevalence of cognitive difficulties in cancer patients receiving chemotherapy compared to the general population as well a…

    Stage
    Not phased
    Ages
    21 and older
    Site
    University of Rochester, Rochester, New York
    Run by
    University of Rochester

    See if you can join NCT03137095 on ClinicalTrials.gov

  11. Microbiome and Association With Implant Infections

    The most common tissue expander-related infections are from Staphylococcus and Pseudomonas species. In addition, from breast tissue microbiome studies, Staphylococcus and Pseudomonas show variable abundance across samples. The investigator hypothesizes that participants undergoing mastectomy with h…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of California, San Francisco, San Francisco, California
    Run by
    University of California, San Francisco

    See if you can join NCT05020574 on ClinicalTrials.gov

  12. GammaPod Registry and Quality of Life Nomogram

    This study is a prospective, single arm study (registry) summarizing patient-level adverse-event and tumor outcomes as well as a number of feasibility and dosimetric characteristics of delivering a single-fraction boost with the GammaPod.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Upper Chesapeake Health, Bel Air, Maryland
    Locations
    4 in total
    Run by
    University of Maryland, Baltimore

    See if you can join NCT03562273 on ClinicalTrials.gov

  13. Cognitive Rehabilitation Following Breast Cancer Treatment

    The goal of this proposed project is to evaluate the feasibility and preliminary effect of metacognitive strategy training to improve activity performance, cognition, and quality of life in breast cancer survivors with cancer-related cognitive impairment (CRCI). The other goal of this proposed proj…

    Stage
    Not phased
    Ages
    20 to 75
    Site
    University of Missouri, Columbia, Missouri
    Run by
    University of Missouri-Columbia

    See if you can join NCT06545045 on ClinicalTrials.gov

  14. Breast Cancer Resiliency Through Exercise Program (B-REP)

    The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and waitlist control among 30 Black …

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Michigan, Ann Arbor, Michigan
    Run by
    University of Michigan Rogel Cancer Center

    See if you can join NCT06100263 on ClinicalTrials.gov

  15. Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management

    This phase II study evaluates SABR as non-operative treatment for women aged 65+ with ER-positive, HER2-negative breast cancer ≤5 cm and no lymph node involvement. Eligible patients, including those previously on endocrine therapy, receive 5 SABR treatments, followed by monitoring of quality of lif…

    Stage
    Not phased
    Ages
    65 and older
    Site
    University of Kansas Medical Center, Kansas City, Kansas
    Locations
    2 in total
    Run by
    University of Kansas Medical Center

    See if you can join NCT07242118 on ClinicalTrials.gov

  16. EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

    The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.

    Stage
    Not phased
    Ages
    20 to 89
    Site
    Allegheny General Hospital, Pittsburgh, Pennsylvania
    Run by
    Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

    See if you can join NCT06115486 on ClinicalTrials.gov

  17. Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)

    The PROSPECTIVE trial aims to find out if using the results of Magnetic Resonance Imaging (MRI) for early breast cancer can select people to not have radiotherapy and still have a low chance of the cancer coming back after surgery. The main question it aims to answer is: * Will cancer come back in …

    Stage
    Not phased
    Ages
    50 and older
    Site
    Mater Hospital, Sydney, North Sydney, New South Wales
    Locations
    9 in total
    Run by
    Breast Cancer Trials, Australia and New Zealand

    See if you can join NCT06445738 on ClinicalTrials.gov

  18. THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation

    The study's purpose is to evaluate whether creatine supplementation can help breast cancer survivors respond quicker to exercise by improving strength, endurance, and body composition. We are seeking to compare information collected from healthy woman of the same age who have never had breast cance…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    The University of Texas Medical Branch, Galveston, Galveston, Texas
    Run by
    The University of Texas Medical Branch, Galveston

    See if you can join NCT06395506 on ClinicalTrials.gov

  19. Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

    The goal of this study is to learn more about how exercise might lower the risk of developing breast cancer in women with dense breast tissue by studying changes that occur in breast tissue and blood as a result of participating in an exercise program. The names of the study groups in this study ar…

    Stage
    Not phased
    Ages
    18 to 59
    Site
    Dana Farber Cancer Institute, Boston, Massachusetts
    Locations
    2 in total
    Run by
    Dana-Farber Cancer Institute

    See if you can join NCT06322888 on ClinicalTrials.gov

  20. Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

    The purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sustainable and practical way of training radiologists in Nigeria to perform and clinically implement US-guided breast biopsies into their pract…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
    Locations
    8 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT05561842 on ClinicalTrials.gov

  21. UCF MammoChat: Image Repository

    This study aims to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participants donate and their responses from study questionnaire to improve patient outcomes. This study also aims to provide mammography images to par…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Central Florida, Orlando, Florida
    Run by
    University of Central Florida

    See if you can join NCT07214883 on ClinicalTrials.gov

  22. Time Restricted Eating During Chemotherapy for Breast Cancer

    Breast cancer is the most common cancer in the United States however, little is known about how diet can affect cancer treatment. Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed research wil…

    Stage
    Not phased
    Ages
    25 to 99
    Site
    University of Illinois Chicago, Chicago, Illinois
    Run by
    University of Illinois at Chicago

    See if you can join NCT05259410 on ClinicalTrials.gov

  23. The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project

    Many breast cancer survivors (estimated 70% in some studies) experience clinically significant depression and/or anxiety in the months and years after finishing cancer treatments. This research will build on the rigor of prior research to reduce breast cancer survivor depression and anxiety with a …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Arizona, Tucson, Arizona
    Run by
    University of Arizona

    See if you can join NCT05676255 on ClinicalTrials.gov

  24. Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

    The purpose of this study is to learn whether clinical response (the amount a tumor shrinks based on imaging or tumor measurements obtained by physical exam) predicts pathologic response (the amount of tumor remaining when surgery is performed) in participants with breast cancer who are receiving c…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Harris Health System - Smith Clinic, Houston, Texas
    Locations
    2 in total
    Run by
    Baylor Breast Care Center

    See if you can join NCT05020860 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.